November 06, 2026 FDA approves amivantamab for head and neck cancer Accelerated approval follows a 42% response rate in 102 patients previously treated with chemotherapy and immunotherapy. MDSpire News
November 03, 2026 FDA tentatively approves generic lenacapavir The twice-yearly injection could expand access to affordable HIV prevention across 120 countries. MDSpire News
October 30, 2026 FDA approves tildrakizumab for psoriatic arthritis The IL-23 inhibitor gains a new indication after 2 phase 3 trials show improved joint responses versus placebo. MDSpire News
October 29, 2026 FDA, CMS target gene therapy barriers FDA and CMS initiatives aim to simplify gene therapy approvals and expand access to treatments for rare diseases. MDSpire News
October 29, 2026 CDC mandates Ebola attestation for US-bound flights The new requirement applies to US citizens, permanent residents, and foreign travelers. MDSpire News
October 28, 2026 FDA adds generic valganciclovir oral solution The new option is indicated for CMV prophylaxis in pediatric kidney and heart transplant recipients, as well as adult CMV retinitis and transplant prophylaxis. MDSpire News
October 27, 2026 Endometrial cancer drug cuts progression or death risk 41% FDA grants Priority Review following improved survival versus chemotherapy in phase 3 trial. MDSpire News
October 27, 2026 FDA expands talazoparib use in prostate cancer The combination with enzalutamide reduced the risk of radiographic progression or death by 52% . MDSpire News
October 27, 2026 CDC chief medical officer resigns after 6 months Jennifer Shuford, MD, MPH, will leave the agency November 12, with an acting successor named. MDSpire News
October 26, 2026 FDA expands weekly insulin use to children Insulin icodec-abae offers a weekly basal insulin option for pediatric type 2 diabetes, supported by adult trials and pediatric pharmacokinetic data. MDSpire News